Literature DB >> 19477640

Synthesis and evaluation of 9-O-substituted berberine derivatives containing aza-aromatic terminal group as highly selective telomeric G-quadruplex stabilizing ligands.

Yan Ma1, Tian-Miao Ou, Jia-Heng Tan, Jin-Qiang Hou, Shi-Liang Huang, Lian-Quan Gu, Zhi-Shu Huang.   

Abstract

A series of new 9-O-substituted berberine derivatives (4a-j) as telomeric quadruplex ligands was synthesized and evaluated. The results from biophysical and biochemical assay indicated that introducing of positive charged aza-aromatic terminal group into the side chain of 9-position of berberine significantly improved the binding ability with G-quadruplex, and exhibited the inhibitory effect on the hybridization and on telomerase activity. These derivatives showed excellent selectivity for telomeric G-quadruplex DNA over duplex.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19477640     DOI: 10.1016/j.bmcl.2009.05.030

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  16 in total

1.  Glycoside hydrolase family 18 and 20 enzymes are novel targets of the traditional medicine berberine.

Authors:  Yanwei Duan; Tian Liu; Yong Zhou; Tongyi Dou; Qing Yang
Journal:  J Biol Chem       Date:  2018-08-22       Impact factor: 5.157

2.  Pyridine Derivative of the Natural Alkaloid Berberine as Human Telomeric G4-DNA Binder: A Solution and Solid-State Study.

Authors:  Francesco Papi; Carla Bazzicalupi; Marta Ferraroni; Giulia Ciolli; Paolo Lombardi; Asma Yasmeen Khan; Gopinatha Suresh Kumar; Paola Gratteri
Journal:  ACS Med Chem Lett       Date:  2020-02-07       Impact factor: 4.345

3.  The formation and stabilization of a novel G-quadruplex in the 5'-flanking region of the relaxin gene.

Authors:  Sen Lin; Huiping Gu; Ming Xu; Xiaojie Cui; Youyi Zhang; Wei Gao; Gu Yuan
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

4.  Biophysical characterization of the strong stabilization of the RNA triplex poly(U)•poly(A)*poly(U) by 9-O-(ω-amino) alkyl ether berberine analogs.

Authors:  Debipreeta Bhowmik; Suman Das; Maidul Hossain; Lucy Haq; Gopinatha Suresh Kumar
Journal:  PLoS One       Date:  2012-05-29       Impact factor: 3.240

5.  Chemical intervention of the NM23-H2 transcriptional programme on c-MYC via a novel small molecule.

Authors:  Chan Shan; Jing Lin; Jin-Qiang Hou; Hui-Yun Liu; Shuo-Bin Chen; Ai-Chun Chen; Tian-Miao Ou; Jia-Heng Tan; Ding Li; Lian-Quan Gu; Zhi-Shu Huang
Journal:  Nucleic Acids Res       Date:  2015-06-27       Impact factor: 16.971

6.  A newly identified berberine derivative induces cancer cell senescence by stabilizing endogenous G-quadruplexes and sparking a DNA damage response at the telomere region.

Authors:  Yun-Xia Xiong; Hua-Fei Su; Peng Lv; Yan Ma; Shi-Ke Wang; Hui Miao; Hui-Yun Liu; Jia-Heng Tan; Tian-Miao Ou; Lian-Quan Gu; Zhi-Shu Huang
Journal:  Oncotarget       Date:  2015-11-03

Review 7.  Telomerase Inhibitors from Natural Products and Their Anticancer Potential.

Authors:  Kumar Ganesan; Baojun Xu
Journal:  Int J Mol Sci       Date:  2017-12-21       Impact factor: 5.923

8.  Ligand binding to telomeric G-quadruplex DNA investigated by funnel-metadynamics simulations.

Authors:  Federica Moraca; Jussara Amato; Francesco Ortuso; Anna Artese; Bruno Pagano; Ettore Novellino; Stefano Alcaro; Michele Parrinello; Vittorio Limongelli
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-23       Impact factor: 11.205

9.  The crystal structure of human telomeric DNA complexed with berberine: an interesting case of stacked ligand to G-tetrad ratio higher than 1:1.

Authors:  Carla Bazzicalupi; Marta Ferraroni; Anna Rita Bilia; Francesca Scheggi; Paola Gratteri
Journal:  Nucleic Acids Res       Date:  2012-10-26       Impact factor: 16.971

10.  New insights into transcription fidelity: thermal stability of non-canonical structures in template DNA regulates transcriptional arrest, pause, and slippage.

Authors:  Hisae Tateishi-Karimata; Noburu Isono; Naoki Sugimoto
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.